Walden Group Healthcare M&A Blog

  • Biosynth Carbosynth Acquires Aalto Bio Reagents

      Biosynth Carbosynth, a provider of life science research products and contract manufacturing services, has purchased Ireland-based Aalto Bio Reagents, a supplier of biological materials serving the in-vitro diagnostic (IVD) and vaccine development markets.  In March 2022, Biosynth acquired vivitide, a provider of custom peptides and...
    Read More
  • The Walden Group Releases Q1 2022 Strategic Healthcare M&A Report

    The Walden Group is pleased to provide access to its Q1 2022 Strategic Healthcare M&A Report, which includes:       Market Overview       Major M&A Deals by Sector       What the Leading CEOs are Saying       Performance of Leading Healthcare Companies       Analysis of More Than 50 Q1 M&A...
    Read More
  • The Walden Group was Engaged by Katalyst Surgical, LLC and Initiated Its Merger with Carl Zeiss Meditec AG

     The Walden Group is pleased to announce that it was engaged by Katalyst Surgical, LLC and initiated its merger with an affiliate of Carl Zeiss Meditec AG, one of the world’s leading medical technology companies traded on the German Stock Exchange. Katalyst Surgical is a leader in vitreoretinal instruments, fiberoptic illumination, innovative...
    Read More
  • Integer Acquires Aran Biomedical

    Integer Holdings Corporation, a $1.2b device outsource manufacturer has acquired Ireland-based Aran Biomedical, a producer of proprietary medical textiles, high precision biomaterial coverings and coatings and advanced metal and polymer braiding for implantable devices.  Aran Biomedical enables Integer to penetrate high growth cardiovascular...
    Read More
  • Teamvantage Acquires MMD Medical

    Custom contract manufacturer and injection molder Teamvantage has acquired MMD Medical, a contract manufacturer of components for large medical OEMs. The deal will enable Teamvantage to create a one-stop-shop with differentiated precision manufacturing capabilities. Teamvantage is a portfolio company of private equity firm Graham Partners. MMD...
    Read More